Straumann Holding AG (SAUHY)
USD 12.99
(0.62%)
USD 12.99
(0.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 410.97 Million CHF | -24.55% |
| 2022 | 535.35 Million CHF | -1.33% |
| 2021 | 542.57 Million CHF | 246.61% |
| 2020 | 156.54 Million CHF | -59.56% |
| 2019 | 387.14 Million CHF | 12.99% |
| 2018 | 342.63 Million CHF | 20.8% |
| 2017 | 283.63 Million CHF | 24.85% |
| 2016 | 227.17 Million CHF | 31.64% |
| 2015 | 172.56 Million CHF | 16.35% |
| 2014 | 148.31 Million CHF | 28.1% |
| 2013 | 115.78 Million CHF | 89.78% |
| 2012 | 61.01 Million CHF | -23.66% |
| 2011 | 79.92 Million CHF | -51.36% |
| 2010 | 164.31 Million CHF | -0.62% |
| 2009 | 165.33 Million CHF | 309.18% |
| 2008 | 40.4 Million CHF | -79.95% |
| 2007 | 201.51 Million CHF | 14.94% |
| 2006 | 175.32 Million CHF | 12.43% |
| 2005 | 155.93 Million CHF | 22.82% |
| 2004 | 126.96 Million CHF | 27.96% |
| 2003 | 99.22 Million CHF | 32.73% |
| 2002 | 74.76 Million CHF | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 336.05 Million CHF | 202.25% |
| 2023 Q4 | 111.18 Million CHF | -62.02% |
| 2023 Q2 | 292.71 Million CHF | 40.52% |
| 2023 FY | 403.89 Million CHF | -24.55% |
| 2022 Q4 | 208.3 Million CHF | -35.35% |
| 2022 Q2 | 322.19 Million CHF | 23.79% |
| 2022 FY | 535.35 Million CHF | -1.33% |
| 2021 Q4 | 260.27 Million CHF | -5.77% |
| 2021 FY | 542.57 Million CHF | 246.61% |
| 2021 Q2 | 276.22 Million CHF | 16.45% |
| 2020 Q2 | 79.09 Million CHF | -61.57% |
| 2020 FY | 156.54 Million CHF | -59.56% |
| 2020 Q4 | 237.2 Million CHF | 199.89% |
| 2019 Q2 | 168.5 Million CHF | -2.37% |
| 2019 FY | 387.14 Million CHF | 12.99% |
| 2019 Q4 | 205.83 Million CHF | 22.15% |
| 2018 FY | 342.63 Million CHF | 20.8% |
| 2018 Q2 | 178.76 Million CHF | 24.93% |
| 2018 Q4 | 172.59 Million CHF | -3.46% |
| 2017 Q4 | 143.09 Million CHF | 2.34% |
| 2017 Q2 | 139.82 Million CHF | 24.34% |
| 2017 FY | 283.63 Million CHF | 24.85% |
| 2016 Q2 | 114.37 Million CHF | 27.92% |
| 2016 FY | 227.17 Million CHF | 31.64% |
| 2016 Q4 | 112.45 Million CHF | -1.68% |
| 2015 Q4 | 89.4 Million CHF | -6.55% |
| 2015 Q2 | 95.68 Million CHF | 31.42% |
| 2015 FY | 172.56 Million CHF | 16.35% |
| 2014 Q4 | 72.8 Million CHF | -2.93% |
| 2014 FY | 148.31 Million CHF | 28.1% |
| 2014 Q2 | 75 Million CHF | 43.94% |
| 2013 Q2 | 62.82 Million CHF | 0.0% |
| 2013 FY | 115.78 Million CHF | 89.78% |
| 2013 Q4 | 52.1 Million CHF | -17.06% |
| 2012 Q4 | - CHF | 0.0% |
| 2012 FY | 61.01 Million CHF | -23.66% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | 79.92 Million CHF | -51.36% |
| 2010 FY | 164.31 Million CHF | -0.62% |
| 2010 Q4 | - CHF | 0.0% |
| 2009 FY | 165.33 Million CHF | 309.18% |
| 2009 Q4 | - CHF | 0.0% |
| 2008 FY | 40.4 Million CHF | -79.95% |
| 2007 FY | 201.51 Million CHF | 14.94% |
| 2006 FY | 175.32 Million CHF | 12.43% |
| 2005 FY | 155.93 Million CHF | 22.82% |
| 2004 FY | 126.96 Million CHF | 27.96% |
| 2003 FY | 99.22 Million CHF | 32.73% |
| 2002 FY | 74.76 Million CHF | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -35200.287% |
| Ansell Limited | 129.3 Million USD | -217.845% |
| Ansell Limited | 129.3 Million USD | -217.845% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -1219.836% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 25855.013% |
| Psykey, Inc. | -797.5 Thousand USD | 51632.406% |
| ConvaTec Group Plc | 262.7 Million USD | -56.442% |
| ConvaTec Group Plc | 262.7 Million USD | -56.442% |
| Encision Inc. | -640.78 Thousand USD | 64236.065% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 289905.373% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 373949.723% |
| Innovative MedTech Inc. | -4.27 Million USD | 9715.482% |
| LifePoint, Inc. | -7.49 Million USD | 5583.129% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 6442.176% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -124437.273% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 334523.468% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 88050.428% |
| SmileDirectClub, Inc. | -241.15 Million USD | 270.418% |
| Sector 10, Inc. | -39.84 Thousand USD | 1031555.175% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -28.587% |
| SheerVision, Inc. | 155.72 Thousand USD | -263807.761% |
| United Health Products, Inc. | -2.42 Million USD | 17036.592% |
| Vasamed, Inc. | 4.74 Million USD | -8566.108% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 18014.025% |
| Yubo International Biotech Limited | -1.2 Million USD | 34199.333% |